Table 1.
Variable | Patients with primary resistance N=26 | Patients without primary resistance N=92 | Difference between groups (p value) |
---|---|---|---|
Sex, n (%) | p=0.199 | ||
Females | 0 | 7 (7.6%) | |
Males | 26 (100%) | 85 (92.4%) | |
Age (median, 25th and 75th percentile; years) | 30 (28–36) | 36 (29.0–46.0) | p=0.012 |
CD4 T cell count (median, 25th and 75th percentile; cells/μl) | 318 (75–396) | 293 (100.0–511.0) | p=0.633 |
Plasma viremia (median, 25th and 75th percentile; log copies of HIV-1 RNA per ml) | 5.2 (4.6–5.9) | 4.8 (4.2–5.5) | p=0.061 |
Risk factor for infection | |||
Men who have sex with men (MSM) | 20 (76.9%) | 60 (65.2%) | p=0.354a |
Heterosexual group | 3 (11.5%) | 21 (22.8%) | |
Intravenous drug users | 0 | 3 (3.3%) | |
Unknown/declined to answer | 3 (11.5%) | 8 (8.7%) | |
HIV subtypes | |||
B | 26 (100%) | 79 (85.9%) | p=0.038b |
A | 0 | 6 (6.5%) | |
C | 0 | 3 (3.3%) | |
CRF02_AG | 0 | 2 (2.2%) | |
CRF01_AE | 0 | 1 (1.1%) | |
D | 0 | 1 (1.1%) |
Comparison of MSM versus non-MSM.
Comparison of subtype B versus non-B subtypes.
Percentages sums do not equal 100 due to rounding.